Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
SciSparc Shares Surge Following Launch of Quantum Computing Program
SciSparc Terminates Merger Agreement with AutoMax, Repays $4.25 Million ...
SciSparc Ltd. (SPRC) Latest Stock News & Headlines - Yahoo Finance
SciSparc and Clearmind Collaboration Strengthens IP Portfolio with ...
SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen ...
Scisparc Announces Bullish 1-for-26 Reverse Stock Split | Smallcaps Daily
How SciSparc Uses Quantum Computing and AI to Transform 3D Protein ...
SciSparc (NASDAQ: SPRC) surged 59.01% as quantum computing initiative ...
SciSparc Soars 116% on Quantum Computing Breakthrough – What’s Next for ...
SciSparc Initiates Clinical Trial in Tourette Syndrome - PRISM MarketView
SciSparc (SPRC) Surges 36.77% on MitoCareX Merger Approval: A Quantum ...
SciSparc Ltd. (SPRC) Stock Explodes 202% Following NeuroThera's TSX ...
SciSparc (SPRC) Surges 37.48% on MitoCareX Merger Approval and Quantum ...
SciSparc Pursues Patent for Metabolic Health Innovation - Psychedelic ...
From Pharma to Powertrain: SciSparc Shareholders Approve Merger with ...
SciSparc Files Annual Report for Year Ended December 31, 2021 and ...
SciSparc Successfully Completed The Development of its Proprietary Drug ...
SciSparc Stock Price Surged 104.6% After Regaining Compliance
SciSparc bold move: Xylo Technologies and SciSparc patent acquisition deal
SciSparc Reinforces its New JV for Targeting Discovery with a Global ...
Why Is SciSparc Stock (SPRC) Up 130% Today? - TipRanks.com
SciSparc Ltd. (SPRC) Stock: Jumps as Company Expands into High-Growth ...
SciSparc Doses First Patient in Autism Treatment Trial - PRISM MarketView
Scisparc and Clearmind Push into Eating Disorder And Addiction ...
SciSparc (Nasdaq: SPRC) Granted Patent for Core Technology in Multiple ...
SciSparc (NASDAQ: SPRC) Celebrates Major Breakthrough: Positive Results ...
SciSparc Completed Treatment of Last Patient Enrolled for its Phase IIa ...
Scisparc Ltd.'s Strategic Merger with Automax Motors: Unpacking the EV ...
SciSparc Faces Regulatory Challenge with Potential Compliance Comeback
SciSparc Shares Soar 100% with Plans to Launch Quantum Computing ...
SciSparc Expands MedTech Footprint With Strategic IP Acquisition ...
SciSparc (Nasdaq: SPRC) Receives Final Approval to Commence its Phase ...
SciSparc (Nasdaq: SPRC) and Clearmind Collaboration Strengthens IP ...
SciSparc and Clearmind Land South Korean Patent for Cocaine Addiction ...
SciSparc (Nasdaq: SPRC) Granted Another Patent, Strengthening its Core ...
SciSparc (Nasdaq: SPRC) Announces Enrollment of First Patient for its ...
SciSparc Moves Into Med-Tech With Acquisition of Endoscopy Patent ...
SciSparc Ltd. Launches Initiative to Advance 3D Protein Modeling with ...
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb ...
SciSparc Ltd. Announces Additional Positive Results for the Cocaine ...
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields 3rd ...
SciSparc Stocks Surge: A Strategic Leap Forward?
SciSparc (Nasdaq: SPRC) Receives Approval to conduct its Phase IIb ...
SciSparc (Nasdaq: SPRC) and Clearmind Reveal Three Unique Combinations ...
SciSparc Announces Ethics Committee Approval to Conduct its Clinical ...
SciSparc Stock Soars But Is It Sustainable?
SciSparc Plans to Use Quantum Computers to Model 3D Proteins For AI ...
How SciSparc (SPRC) Stock Continued The Rally After-Hours
SciSparc (Nasdaq: SPRC) Announces IRB Approval to Conduct its Phase IIb ...
SciSparc (Nasdaq: SPRC) Signs Non-Binding Letter of Intent to Merge ...
SciSparc Announces Major Breakthrough with Alzheimer's Treatment ...
SciSparc Shares Skyrocket: Automotive Expansion?
SciSparc Secures Renewed Approval by Israel Cannabis Agency for ...
SciSparc conducts CBD oil clinical trial for children with autism : r/CBD
SciSparc Announces IRB Approval to Conduct its Phase IIb Trial in ...
SciSparc to Collaborate with Polyrizon for Brain Targeting Using ...
SciSparc on LinkedIn: SciSparc Granted Patent from the Australian ...
SciSparc Ltd. (Nasdaq: SPRC) Announces Pricing of $5.026 Million ...
SciSparc Ltd (SPRC) Chart - ADVFN
SciSparc Faces Nasdaq Non-Compliance Challenge Over Stockholders’ Equity
SciSparc (Nasdaq: SPRC) Receives Approval to Conduct its Clinical Trial ...
SciSparc (NASDAQ: SPRC) stock to rise 2,600% today - one of those ...
SciSparc gets clearance for Tourette Syndrome therapy trial
SciSparc (Nasdaq: SPRC) completes the sale of a 49% interest in its ...
SciSparc (Nasdaq: SPRC) to Acquire AutoMax - TraDigital IR
SciSparc director Shrem Itschak reports holdings | SPRC Insider Trading
SciSparc Ltd. (SPRC) stock: dips nearly 12% as company unveils ...
SciSparc Secures Strategic Advantage with Grant of European Patent ...
SciSparc Announces Israeli Approval Renewal for ASD Trial
SciSparc and Clearmind Medicine Reflect on Successful Collaboration in ...
SciSparc (Nasdaq: SPRC) Announces Positive Results from its Weight Loss ...
SciSparc | LinkedIn
SciSparc Expands Biotech Presence Through Acquisition of Miza III Ventures
SciSparc (NASDAQ:SPRC) Shares Down 3.8% – Here’s Why - American Banking ...
SciSparc Surges 59% on $590M Volume Ranks 201st in U.S. Equities Amid ...
SciSparc (Nasdaq: SPRC) Enters Into Non-Binding Letter of Intent to ...
SciSparc Ltd: SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to ...
SciSparc (Nasdaq: SPRC) Provides Updates Regarding the Non-Binding ...
SciSparc Ltd. (Nasdaq: SPRC): Pioneering Breakthroughs in Central ...
SciSparc (Nasdaq: SPRC) Announces Corporate Restructuring plan ...
SciSparc (Nasdaq: SPRC) Signs a Definitive Agreement to Sell 49% ...
SciSparc (Nasdaq: SPRC) Makes Another Step Towards Unlocking Potential ...
SciSparc Shares Surge: Time to Invest?
SciSparc (Nasdaq: SPRC) Granted Patent for its Core Technology From the ...
SciSparc Ltd.: A Pathbreaking Pharma Play Catering To Central Nervous ...
SciSparc (SPRC) Stock Soaring Following An Equity Move
SciSparc Investor Deck February 2022 | PDF
Breaking Ground in Mental Health: SciSparc and Clearmind's Patent ...
SciSparc (Nasdaq: SPRC): MitoCareX Reveals Promising Results with ...
SciSparc Unit Buys 54% Stake in Quantum Tech Firm
SciSparc to Spin Off Advanced Clinical Stage Pharmaceutical Portfolio ...
Why SciSparc (SPRC) Stock Is Skyrocketing Today - SciSparc (NASDAQ:SPRC ...
Stock Data – Investors – SciSparc
SciSparc, Automax enters direct import market with $13M first shipment ...
SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles ...
NeuroThera expands private placement to C$5.4M
SciSparc's JV MitoCareX Bio Launches its Advanced New Laboratory ...
SciSparc-Clearmind Collaboration Unveils Breakthrough Psychedelic ...
April 21 2023
Investing in SciSparc: Tel Aviv Biotech's Rise in Cannabinoid CNS ...
SciSparc's Patent Spark Ignites FOMO-Driven Rally—But Financial Reality ...
SciSparc's Patent Play: Assessing the Exponential Potential of ...
SciSparc(Nasdaq: SPRC) - Clearmind Collaboration Evolves with New ...
SciSparc: (Nasdaq: SPRC) MitoCareX Unveils Groundbreaking Discovery of ...
Clinical Trials Arena
SciSparc's Patent Bet: Assessing the S-Curve Position in Disposable ...
Investors are finding healthy returns in this specialty pharma company
SciSparc’s Stock Slip: Investment Opportunity?
SciSparc’s NeuroThera Labs Secures Israeli Patent for Proprietary ...
SciSparc's Board of Directors Provides Strategic Decision - TraDigital IR
SciSparc's Nasdaq Compliance and the Cannabis-Pharma Convergence: A ...
SciSparc's Strategic IP Play: A Catalyst for Market Capture in Next-Gen ...
SciSparc's Breakthrough Pain Patent: A Game-Changer in Safer Analgesics?
Polyrizon pays $3M for license to SciSparc’s preclinical cannabinoid ...
Acted as Exclusive Placement Agent on a $10M Private Placement Priced ...
Thank You Investor Contact: IR@scisparc.com Tel: + 972 - 3 - 6167055 ...
SPRC Stock Explodes As Bullish Upgrades Hit Tape - StocksToTrade
